Cargando…
BRCA2 C-Terminal RAD51-Binding Domain Confers Resistance to DNA-Damaging Agents
Breast cancer type 2 susceptibility (BRCA2) protein is crucial for initiating DNA damage repair after chemotherapy with DNA interstrand crosslinking agents or X-ray irradiation, which induces DNA double-strand breaks. BRCA2 contains a C-terminal RAD51-binding domain (CTRBD) that interacts with RAD51...
Autores principales: | Zhu, Zida, Kitano, Taisuke, Morimatsu, Masami, Tanaka, Arisa, Morioka, Ryo, Lin, Xianghui, Orino, Koichi, Yoshikawa, Yasunaga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000072/ https://www.ncbi.nlm.nih.gov/pubmed/35409418 http://dx.doi.org/10.3390/ijms23074060 |
Ejemplares similares
-
A Highly Conserved Region in BRCA2 Suppresses the RAD51-Interaction Activity of BRC Repeats
por: Zhu, Zida, et al.
Publicado: (2023) -
Identification of the core motif of the BRCA2 C-terminal RAD51-binding domain by comparing canine and human BRCA2
por: YOSHIKAWA, Yasunaga, et al.
Publicado: (2021) -
Reduced translation efficiency due to novel splicing variants in 5′ untranslated region and identification of novel cis-regulatory elements in canine and human BRCA2
por: Yoshikawa, Yasunaga, et al.
Publicado: (2021) -
Contributions of the RAD51 N-terminal domain to BRCA2-RAD51 interaction
por: Subramanyam, Shyamal, et al.
Publicado: (2013) -
Reduced canine BRCA2 expression levels in mammary gland tumors
por: Yoshikawa, Yasunaga, et al.
Publicado: (2015)